Exchange: NASDAQ·Updated 07:30 PM EST

RTSN News

News
all
press releases
Wall Street Zen cut Retension Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat
Retension Pharmaceuticals (NASDAQ:RTSN - Get Free Report) issued its earnings results on Wednesday. The company reported ($7.33) earnings per share (EPS) for the quarter...
MarketBeat

Advertisement|Remove ads.